<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-NWS6QFW" height="0" width="0" style="display:none;visibility:hidden">

Tactics for Agile in Biopharma Research & Development

Posted by EG Life Sciences
A director of product management shares what works and what doesn't when implementing Agile within drug discovery organizations. Learn more today.

Read More »

Scrumming Scientific Project Management

Posted by EG Life Sciences
Scientist and Agilist Kendra West shares tips for introducing Agile practices within scientific project management. Learn from her findings today.

Read More »

Pharmaceutical Innovation and Agility

Posted by EG Life Sciences
Dr. Terry Barnhart shares how your company can boost innovation through Agile pharmaceuticals. Start accelerating your innovation today.

Read More »

Celebrating Eliassen Group’s Brand Evolution and Expanded Service Offerings

Posted by EG Life Sciences
EG Life Sciences is sharing the news of Eliassen Group’s updated brand. Read more about what this means for us – and our clients.

Read More »

EU IVDR Requirements for Certification

Posted by EG Life Sciences
Most IVD manufacturers are taking the necessary steps to prepare to comply with the IVDR. Are you ready to meet the IVDR requirements for Certification?

Read More »

How to Handle Out of Specification (OOS) Results

Posted by EG Life Sciences
Do you know how to handle drug product that is considered “out of specification,” or OOS? Be prepared in case it ever happens to you.

Read More »

Net Promoter Scores: What Do the Numbers Really Mean?

Posted by EG Life Sciences
Net Promoter Scores are derived with one basic question in mind: How likely are you to recommend your firm to a friend or colleague? This blog post explains what an NPS is, how it’s measured, and what this number actually tells you.

Read More »

FDA Form 483 vs. FDA Warning Letters: What's the Difference?

Posted by EG Life Sciences
After the FDA inspects a company’s manufacturing facilities, they might send an FDA Form 483 or an FDA warning letter. Find out what to expect from both.

Read More »

The FDA is On-Site! Checklist for FDA Site Inspections

Posted by EG Life Sciences
Is your Site Inspection Readiness team prepared for FDA visits, especially when they are unannounced? Make sure you have this FDA audit checklist on hand.

Read More »

Prepping for a Successful FDA Site Inspection: Readiness Team

Posted by EG Life Sciences
For life sciences companies, FDA inspection readiness is a necessity. Some FDA site inspections are surprise visits, so it’s wise to have a plan in place.

Read More »

Are you attending PhUSE in Deerfield, IL?

Posted by EG Life Sciences
PhUSE is hosting the event, “Utilizing Risk-Based Monitoring to Identify and Mitigate Risk While Ensuring Patient Safety, Data Quality and Integrity”

Read More »

Subscribe to our Blog